Clinical Trial Update: Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies [Phase 1, Phase 2]

View source ↗

Summary

This update presents safety and pharmacokinetic data from a Phase 1/2 trial of orally administered gallium maltolate in refractory malignancies, with the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Lymphoma
• Multiple Myeloma
• Prostate Cancer

Drugs mentioned

• Gallium maltolate (gallium maltolate)

Snippet

Sponsor: Titan Pharmaceuticals | Conditions: Prostatic Neoplasms, Multiple Myeloma | Phase 1, Phase 2 | Status: TERMINATED